10-K/APeriod: FY2020

Rocket Lab Corp Annual Report (Amendment), Year Ended Dec 31, 2020

Filed May 3, 2021For Securities:RKLB

Summary

This 10-K filing by Vector Acquisition Corporation (now Rocket Lab Corp.) on May 3, 2021, is an amendment to restate its previously issued financial statements for the period ended December 31, 2020. The primary reason for the restatement is the accounting treatment of warrants issued in its September 2020 initial public offering. Initially classified as equity, the company's management, following SEC guidance, reclassified these warrants as derivative liabilities, requiring fair value adjustments each reporting period. This change impacts the reported net loss but does not affect cash flow or operating expenses. Notably, the company is a SPAC that has entered into a merger agreement with Rocket Lab, USA, Inc., with the business combination expected to close in Q2 2021. A PIPE financing of $467 million has been secured. As of the filing date, the company had not commenced operations and generated no revenue, relying on interest income from its trust account and incurring costs related to its public company status and business combination pursuit. The restatement also led to a determination that disclosure controls and procedures were not effective as of December 31, 2020, primarily due to the warrant accounting issue.

Financial Statements
Beta

Key Highlights

  • 1The company is restating its 2020 financial statements primarily due to the reclassification of warrants from equity to derivative liabilities, following SEC guidance for SPACs.
  • 2This restatement impacts the reported net loss due to fair value adjustments of the warrant liability but does not affect cash, cash equivalents, revenue, or cash flows.
  • 3Vector Acquisition Corporation, a SPAC, has announced a business combination with Rocket Lab, USA, Inc., with the transaction expected to close in the second quarter of 2021.
  • 4A Private Investment in Public Equity (PIPE) financing of $467 million has been secured from investors to support the business combination.
  • 5As of December 31, 2020, the company had no operating revenues and incurred formation and operating expenses, with significant funds held in a trust account for the business combination.
  • 6The restatement resulted in a conclusion that disclosure controls and procedures were not effective as of December 31, 2020, due to the warrant accounting misapplication.
  • 7The company is an emerging growth company and a smaller reporting company, and it is not a shell company as of the filing date (though it was prior to the business combination announcement).

Frequently Asked Questions

The financial statements are being restated because the company initially accounted for its outstanding warrants as components of equity. Following a review prompted by SEC guidance, management concluded that these warrants should have been classified as derivative liabilities, requiring re-measurement at fair value each reporting period and recognition of changes in the statement of operations.

The restatement affects the reported net loss due to the revaluation of the warrant liability. However, it did not have any effect on the company's previously reported operating expenses, cash flows, or cash balances.

The company has entered into a merger agreement with Rocket Lab, USA, Inc., and expects the business combination to close in the second quarter of 2021, subject to customary closing conditions. A significant PIPE financing of $467 million has also been secured.

No, as of December 31, 2020, the company had not engaged in any operations and had not generated any revenues. Its activities were primarily organizational and focused on identifying and executing a business combination. It anticipates generating operating revenues only after the completion of its business combination.